Cardiac Biomarkers Market

1
Cardiac Biomarkers Market To Reach USD 14.29
Billion By 2026
www.reportsanddata.com
sales_at_reportsanddata.com
2
Market Summary
High target disease prevalence, product launches,
increasing strategic developments such as
partnerships and agreements, favourable research
funding scenario are key factors contributing to
high CAGR of Cardiac Biomarkers during forecast
period. Market Size USD 6.44 Billion in 2018,
Market Growth - CAGR of 10.4. Market Trends
Product launches and research for Cardiac
biomarkers.
3
Our Approach
Market Summary

• According to the Centre for Disease Control and
  Prevention (CDC), for around 610,000 people die
  of heart disease in United States every year,
  thats 1 in every 4 deaths and more than half of
  the deaths due to heart disease were in men.
  Cardiac biomarkers are protein-based observable
  materials discharged into blood when the hearts
  muscles are wounded which can be used as risk
  stratification for numerous cardiovascular
  diseases (CVDs) that includes Acute Myocardial
  Infarction (AMI), Ischemia, Congestive Heart
  Failure (CHF), Acute Coronary Syndrome (ACS) and
  others related with insufficient blood flow to
  heart.
• The high occurrence rates of CVDs worldwide and
  the growing demand for POC cardiac testing kits
  are expected to fuel the market growth. Certain
  manufacturing, limited specificity and
  pharmacological issues and regulatory hurdles are
  hindering the growth of the market.
• Development of products from leading companies
  has been propelling the growth of this market. In
  July 2018, FDA cleared Siemens Healthineers
  high-sensitivity troponin I assays (TnIH) for
  Atellica IM and ADIVA Centaur XP/XPT in vitro
  disnostic analyzers from Siemens Healthineers to
  speed up the time for detection of diagnosis of
  myocardial infarctions.
• Request for a sample of this research report _at_
  https//www.reportsanddata.com/sample-enquiry-form
  /1423

4
Our Approach
Market Summary

• Further key findings from the report suggest
• Cardiac Biomarkers market is fastest growing at a
  CAGR of 3 in Asia Pacific due to high awareness
  about biomarkers and rise in aging population and
  even rising incidences of CVDs.
• The market for point of care testing type segment
  is expected to hold the fastest growing CAGR
  because of increase in demand for speedy
  monitoring patients by doctors and clinicians.
• Europe is the second largest region with a share
  of 28.5 due to the high cases of cardiovascular
  diseases in France, Ireland, etc.
• Brain Natriuretic Peptide is accounted to be the
  second leading segment which holds a market share
  of 27.6 due to high usage and perfect accuracy
  rate for detecting Congestive Heart Failure.
• Diagnostic Laboratories segment is projected to
  have the highest CAGR among the other end user
  type.
• North America is expected to account for the
  40.1 of the global Cardiac Biomarkers market
  owing to the affordability for advanced cardiac
  treatments, modernisation etc.
• To identify the key trends in the industry, click
  on the link below https//www.reportsanddata.com/
  report-detail/cardiac-biomarkers-market

5
Our Approach
Market Summary

• Key participants include Abbott Laboratories,
  Alere Inc. and Roche Diagnostics Corporation.
• For the purpose of the study, this Reports and
  Data has segmented the Global Cardiac Biomarkers
  Market on the basis of biomolecule type, disease
  type, profiling technologies, application,
  services and the regional outlook
• Product Type (Revenue, USD Million 20162026)
• Brain Natriuretic Peptide (BNPs) or NT-proBNP
• Ischemia Modified Albumin (IMA)
• Myoglobin
• Troponins (T and I)
• Myocardial muscle Creatine Kinase (CK-MB)
• Others
• Location of Testing (Revenue, USD Million
  20162026)
• Laboratory Testing
• Point of Care Testing

6
Our Approach
Market Summary

• Application (Revenue, USD Million 20162026)
• Myocardial Infarction
• Congestive Heart Failure
• Acute Coronary Syndrome
• Atherosclerosis
• Others
• End User (Revenue, USD Million 20162026)
• Diagnostic Laboratories
• Hospitals and Clinics
• Order Now https//www.reportsanddata.com/checkout
  -form/1423

7
Our Approach
About Us

• Reports and Data is a market research and
  consulting company that provides syndicated
  research reports, customized research reports,
  and consulting services. Our solutions purely
  focus on your purpose to locate, target and
  analyze consumer behavior shifts across
  demographics, across industries and help clients
  make a smarter business decision. We offer market
  intelligence studies ensuring relevant and
  fact-based research across a multiple industries
  including Healthcare, Technology, Chemicals,
  Power, and Energy. We consistently update our
  research offerings to ensure our clients are
  aware about the latest trends existent in the
  market. Reports and Data has a strong base of
  experienced analysts from varied areas of
  expertise.
• Contact Us
• John Watson
• Head of Business Development
• Reports And Data Web www.reportsanddata.com
• Direct Line 1-212-710-1370
• E-mail sales_at_reportsanddata.com